Dermal Fillers Market Set to Surpass USD 10.97 Billion in 2032, says Coherent Market Insights [Yahoo! Finance]
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
is expected to reach USD 10.97 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032. This notable growth is fueled by the rising consumer preference for minimally invasive cosmetic treatments and the increasing global awareness of aesthetic enhancement options. Additionally, technological advancements and the introduction of innovative filler products with enhanced safety features are further propelling market expansion. Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/8388 Global Dermal Fillers Market Key Takeaways Hyaluronic acid is expected to remain a highly sought-after material type, accounting for 35.2% of the global dermal fillers market share by 2025. Facial wrinkle treatment is projected to be the most lucrative application for dermal fillers, with a market share of 23.4% in 2025. Biodegradable/absorbable fillers are expected to remain the top-selling product type, capturing a market share of 55.
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIKGlobeNewswire
- Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? [Yahoo! Finance]Yahoo! Finance
- Anika Therapeutics (NASDAQ:ANIK) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Anika Therapeutics (NASDAQ:ANIK) had its price target raised by analysts at Barrington Research from $15.00 to $16.00. They now have an "outperform" rating on the stock.MarketBeat
- Anika Reports Third Quarter 2025 Financial ResultsGlobeNewswire
ANIK
Earnings
- 11/5/25 - Beat
ANIK
Sec Filings
- 11/21/25 - Form SCHEDULE
- 11/7/25 - Form SCHEDULE
- 11/5/25 - Form S-8
- ANIK's page on the SEC website